| [1] |
Liang S, Wang C, Zhang J, et al. Triglyceride-glucose index and coronary artery disease: A systematic review and meta-analysis of risk, severity, and prognosis[J]. Cardiovasc Diabetol, 2023, 22(1):170. doi: 10.1186/s12933-023-01906-4.
pmid: 37415168
|
| [2] |
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects[J]. Metab Syndr Relat Disord, 2008, 6(4):299-304. doi: 10.1089/met.2008.0034.
pmid: 19067533
|
| [3] |
Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: A population-based study[J]. BMC Med, 2020, 18(1):361. doi: 10.1186/s12916-020-01824-2.
pmid: 33234146
|
| [4] |
Guo W, Zhu W, Wu J, et al. Triglyceride glucose index is aassociatedwith arterial stiffness and 10-year cardiovascular disease risk in a Chinese population[J]. Front Cardiovasc Med, 2021, 8:585776. doi: 10.3389/fcvm.2021.585776.
|
| [5] |
Qiu Z, Jiang Y, Jiang X, et al. Relationship between platelet to lymphocyte ratio and stable coronary artery disease: Meta-analysis of observational studies[J]. Angiology, 2020, 71(10):909-915. doi: 10.1177/0003319720943810.
|
| [6] |
Kurtul A, Ornek E. Platelet to lymphocyte ratio in cardiovascular diseases: A systematic review[J]. Angiology, 2019, 70(9):802-818. doi: 10.1177/0003319719845186.
pmid: 31030530
|
| [7] |
Sari I, Sunbul M, Mammadov C, et al. Relation of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio with coronary artery disease severity in patients undergoing coronary angiography[J]. Kardiol Pol, 2015, 73(12):1310-1316. doi: 10.5603/KP.a2015.0098.
pmid: 25987404
|
| [8] |
Yüksel M, Yıldız A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity[J]. Anatol J Cardiol, 2015, 15(8):640-647. doi: 10.5152/akd.2014.5565.
pmid: 25550173
|
| [9] |
Won KB, Park EJ, Han D, et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline[J]. Cardiovasc Diabetol, 2020, 19(1):34.doi: 10.1186/s12933-020-01008-5.
|
| [10] |
Thai PV, Tien HA, Van Minh H, et al. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes[J]. Cardiovasc Diabetol, 2020, 19(1):137. doi: 10.1186/s12933-020-01108-2.
pmid: 32919465
|
| [11] |
Wang A, Tian X, Zuo Y, et al. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: A prospective cohort study[J]. Cardiovasc Diabetol, 2021, 20(1):113. doi: 10.1186/s12933-021-01305-7.
pmid: 34039351
|
| [12] |
Liu Q, Cui H, Ma Y, et al. Triglyceride-glucose index associated with the risk of cardiovascular disease: The Kailuan study[J]. Endocrine, 2022, 75(2):392-399. doi: 10.1007/s12020-021-02862-3.
|
| [13] |
Gerrits AJ, Koekman CA, van Haeften TW, et al. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin[J]. Diabetes, 2010, 59(6):1487-1495. doi: 10.2337/db09-1008.
pmid: 20200314
|
| [14] |
Sun Y, Ji H, Sun W, et al. Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases[J]. Eur J Intern Med, 2025, 131:3-14. doi: 10.1016/j.ejim.
pmid: 39510865
|
| [15] |
Wang X, Xu W, Song Q, et al. Association between the triglyceride-glucose index and severity of coronary artery disease[J]. Cardiovasc Diabetol, 2022, 21(1):168.doi: 10.1186/s12933-022-01606-5.
pmid: 36050734
|
| [16] |
Henein MY, Vancheri S, Longo G, etal. Therole of inflammation in cardiovascular disease[J]. Int J Mol Sci, 2022, 23(21):12906. doi: 10.3390/ijms232112906.
|
| [17] |
Cai L, Yan J, Sun L, et al. TyG index and CBC-derived inflammatory indicators individual and mixed effects on all-cause and cardiovascular disease deaths in patients with CHD[J]. Front Cardiovasc Med, 2025, 12:1600097.doi: 10.3389/fcvm.2025.1600097.
|
| [18] |
Gasparyan AY, Ayvazyan L, Mukanova U, et al. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases[J]. Ann Lab Med, 2019, 39(4):345-357.doi: 10.3343/alm.2019.39.4.345.
pmid: 30809980
|
| [19] |
Azab B, Shah N, AkermanM, et al. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction[J]. J Thromb Thrombolysis, 2012, 34(3):326-334. doi: 10.1007/s11239-012-0718-6.
|
| [20] |
Chen Y, Xie K, Han Y, et al. The association between triglyceride-glucose index and its combination with systemic inflammation indicators and all-cause and cardiovascular mortality in the general US population: NHANES 1999-2018[J]. Lipids Health Dis, 2024, 23(1):289.doi: 10.1186/s12944-024-02277-9.
pmid: 39256829
|